Lung cancer

5 currently open clinical trials

Anti-PD-1 monoclonal antibody pembrolizumab versus placebo for patients with lung cancer
EORTC PEARLS
Durvalumab in patients with advanced lung cancer and poor general state of health
SAKK 19/17
Single arm phase II trial evaluating the activity of Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC
ETOP ALERT
A multicentre randomised phase III trial comparing atezolizumab plus bevacizumab and standard chemotherapy versus bevacizumab and standard chemotherapy as first-line treatment in advanced malignant pleural mesothelioma
ETOP BEAT-meso
Adjuvant immunotherapy for limited-stage small cell lung cancer
ACHILES
All cancer types